Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Reconciliation of Numerator and Denominator of Basic and Diluted Earnings per Share

A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands):


	Year Ended December 31,
	2022		2021		2020

Numerator:
Net loss attributable to Surgery Partners, Inc.	$	(54.6)	$	(70.9)	$	(116.1)
Less: Amounts allocated to participating securities (1)	—		(10.3)		(39.5)
Net loss attributable to common stockholders	$	(54.6)	$	(81.2)	$	(155.6)

Denominator:
Weighted average shares outstanding- basic and diluted (2)	91,952		72,427		48,776

Basic and diluted loss per share (2)	$	(0.59)	$	(1.12)	$	(3.19)

Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive:
Stock options	1,459		1,920		712
Restricted shares	679		1,452		981

(1)Includes dividends accrued for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses and was converted to common stock during the second quarter of 2021. There were no participating securities for the year ended December 31, 2022.

(2)The impact of potentially dilutive securities for all periods were not considered because the effect would be anti-dilutive in each of those periods.